FDA Orange Book
Is there a generic for Vusion?
Vusion contains miconazole nitrate, white petrolatum and zinc oxide. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Vusion (miconazole nitrate, white petrolatum and zinc oxide). The Orange Book shows its last listed patent expires March 30, 2028.
Run it in Rivvi
Map Vusion and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Vusion products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| ointment, topical | 0.25%;81.35%;15% | Marketed (Rx) | None | 0 | None |
NDA 021026, held by MYLAN PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Vusion patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 8147852 | March 30, 2028 | Method of use | U-1426 | 021026 |
Vusion NDC codes
Questions
Is there a generic for Vusion?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Vusion (miconazole nitrate, white petrolatum and zinc oxide). The Orange Book shows its last listed patent expires March 30, 2028.
What is the generic name for Vusion?
The active ingredient in Vusion is miconazole nitrate, white petrolatum and zinc oxide, per the FDA Orange Book.
When does the Vusion patent expire?
The last patent listed for Vusion in the Orange Book expires March 30, 2028. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.